Treatment cessation of entecavir in Asian patients with hepatitis B e antigen negative chronic hepatitis B: a multicentre prospective study

Seto, Wai‐Kay; J. Hui, Aric; Wai‐Sun Wong, Vincent; Lai‐Hung Wong, Grace; Sze-Hang Liu, Kevin; Lai, Ching‐Lung; Yuen, Man‐Fung; Lik‐Yuen Chan, Henry

doi:10.1136/gutjnl-2014-307237

Public

Treatment cessation of entecavir in Asian patients with hepatitis B e antigen negative chronic hepatitis B: a multicentre prospective study

Published in Gut • May 15, 2014

Authors:

Wai‐Kay Seto

Aric J. Hui

Vincent Wai‐Sun Wong

Abstract

BACKGROUND AND OBJECTIVE: The off-treatment durability of nucleos(t)ide analogue therapy in Asian hepatitis B e antigen (HBeAg) negative chronic hepatitis B (CHB) and the role of hepatitis B surface antigen (HBsAg) levels in predicting off-treatment durability has not been well investigated. METHODS...

Subject

Entecavir

Medicine

HBsAg

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!